Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Cannaccord 42nd

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Aug 10, 2022 1:05pm

83 Views

Post# 34885379

RE:Cannaccord 42nd

Did the presentation already take place? I thought it was 1:00 p.m. EST, as in starting now.

Trogarzon wrote: So same result as the 20 previous meetings... down after another reheated plate of the same thing we got served the last time... it's like they do these shows to justify their pay checks... bothing achieved take 20.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season